NVIDIA Blackwell Platform

NVIDIA's Blackwell platform delivers a 25x performance improvement over its predecessor Hopper, making trillion-parameter models operational in real time, a feat 30% faster than the typical rival AI accelerator. Each GPU packs 208 billion transistors, enabling inference speeds that prior hardware could not achieve. Roche deployed 2,176 Blackwell GPUs in a 3,500-GPU cluster—the largest in pharma—to run production drug discovery workloads. By comparison, Microsoft's Maia 200 offers 140 billion transistors and 10 petaFLOPS, while AMD's Instinct MI430X provides 200+ TFLOPS; yet Blackwell's ecosystem edge ensures it defines the reference architecture for 2026.